Publications by authors named "Anantha L Duddupudi"

Article Synopsis
  • Severe influenza A virus can cause serious issues like lung damage and breathing problems, and there are currently no good medicines to treat it.
  • A new drug called UH15-38 has been created to stop a harmful process (called necroptosis) that makes the lung problems worse during severe infections.
  • Tests showed that UH15-38 helped reduce lung inflammation and saved lives in infected patients, even when given later in the illness, making it a promising option for treating severe influenza and related conditions.
View Article and Find Full Text PDF

Fentanyl (FEN) is a potent synthetic opioid associated with increasing incidence of opioid use disorder (OUD) and fatal opioid overdose. Vaccine immunotherapy for FEN-associated disorders may be a viable therapeutic strategy. Here, we expand and confirm our previous study in mice showing immunological and antinociception efficacy of our FEN vaccine administered with the adjuvant dmLT.

View Article and Find Full Text PDF

Fentanyl is a major contributor to the devastating increase in overdose deaths from substance use disorders (SUD). A vaccine targeting fentanyl could be a powerful immunotherapeutic. Here, we evaluated adjuvant and delivery strategies for conjugate antigen vaccination with fentanyl-based haptens.

View Article and Find Full Text PDF
Article Synopsis
  • RIPK2 is an important protein that helps control inflammation in the body, and scientists are studying it to find better treatments.
  • A new type of medicine has been created that blocks the action of RIPK2, using a special chemical design to make it work better and more selectively.
  • Tests showed that this new medicine, called compound 18t, is very effective at stopping RIPK2 and related signals, making it a promising option for future use in treating inflammatory diseases.
View Article and Find Full Text PDF

A metal-free oxidative cyclization of -Boc-acrylamides with (diacetoxyiodo)benzene in acetic acid produced 5,5-disubstituted oxazolidine-2,4-diones with the formation of a C-O bond in moderate to excellent yields. In addition, the reaction was diastereospecific with -Boc-2,3-dimethylacrylamides and proceeded with phenyl migration in the case of an -Boc-2-phenylacrylamide to generate a 5-acetoxy-5-benzyloxazolidine-2,4-dione.

View Article and Find Full Text PDF

The allosteric modulator 1-(4-chlorophenyl)-3-(3-(6-(pyrrolidin-1-yl)pyridin-2-yl)phenyl)urea (PSNCBAM-1, 2) bound the cannabinoid receptor 1 (CB) and antagonized G protein coupling. This compound demonstrated potent anorectic effects similar to the CB antagonist rimonabant that once was marketed for the treatment of obesity, suggesting a new chemical entity for the discovery of antiobesity drugs. To increase structural diversity of this class of CB ligands, we designed and synthesized two classes of novel analogues, in which the pyridine ring of 2 was replaced by a pyrimidine ring.

View Article and Find Full Text PDF